Several research in the literature and clinical trials have suggested that more than 70% of cancers (especially solid tumors) are poorly infiltrated by CD8+ T cells, which are the main causes of therapeutic failure, not only for cancer vaccines but also for point blockade control and CAR-T cell therapy [85]. This evidence concerns the gene CD8A and cancer.